Innovus Pharmaceuticals Inc. (fka INNV)

[kkpennies]

good post I remember a pr mentioning another company to compare to

These dynamics could make the stock undervalued relative to many competitors in the space. For example, Viveve Medical Inc. (NASDAQ: VIVE) is a women’s health device company that trades with a market capitalization of nearly $70 million and revenue of about $5 million so far this year. By comparison, Innovus trades with a market capitalization of just $25 million and revenue of $3 million so far this year. If it were to trade at the same multiple, Innovus would be worth $42 million or $0.42 per share – a 68% premium to the current market price.

http://analysis.secfilings.com/articles/125-innovus-pharma-innv-continues-to-execute-with-record-q3-16-revenue